The experiences from our small pilot series prove technical feasibility in the clinical setting.

Clinical trials will now be necessary to investigate the reproducibility of these encouraging data in human application.

In PPH there is vital interest in timely diagnosis of the underlying cause, thus allowing fertility-sparing, minimally invasive and super-selective emergency treatment. In AVMs causing PPH, a positive impact on perinatal morbidity and mortality may be achieved by sonographically guided application of this biological glue.